Advertisement

Regencell Bioscience Holdings Limited RGC

Set alert

Price alert · RGC

All alert types
6.71 USD -0.15 -2.19%

At close · Oct 30

6.71 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
6.61 × 2
Ask
6.71 × 2
6.53 Day range 7.05
4.78 52-week range 52.88
YTD
-68.05%
1 year
-58.96%
Open
6.89
Prev close
6.86
Mkt cap
3.33B
Vol
148.17K
Avg vol
249.90K
EPS
-0.02
P/E
0.00
Div yield
0.00%
More statistics
Low
6.53
High
7.05
Forward P/E
0.00
Beta
1.17
Short ratio
1.71
Inst. own
0.28%
Dividend
0.00
Ex-div date
50-d avg
6.80
200-d avg
17.29
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Jun 16, 2025Split: 38 for 1
  • Jun 26, 2025Earnings: -0.14244; estimate —; surprise —%
  • Nov 18, 2025Earnings: -0.0035; estimate —; surprise —%
  • Jun 15, 2026Earnings: -0.0107; estimate —; surprise —%
  • Oct 28, 2026Earnings: -0.0129; estimate —; surprise —%
Signals (68)
NameDateAgo
SMA: BearishOct 30, 20262 days ago
MACD: Sell SignalOct 26, 20266 days ago
RSI: OverboughtOct 15, 20262 weeks ago
RSI: OverboughtOct 13, 20262 weeks ago
RSI: OverboughtOct 8, 20263 weeks ago
RSI: OverboughtOct 6, 20263 weeks ago
SMA: BullishSep 16, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BullishSep 2, 20262 months ago
MACD: Buy SignalJul 9, 20263 months ago
RSI: OversoldJun 15, 20264 months ago
RSI: OversoldJun 5, 20264 months ago
SMA: BearishJun 4, 20265 months ago
SMA: BearishMay 19, 20265 months ago
SMA: BullishMay 15, 20265 months ago
SMA: BearishMay 12, 20265 months ago
MACD: Sell SignalApr 20, 20266 months ago
SMA: BullishApr 1, 20267 months ago
MACD: Buy SignalMar 19, 20267 months ago
SMA: BearishFeb 23, 20268 months ago
MACD: Sell SignalFeb 23, 20268 months ago
MACD: Buy SignalFeb 17, 20268 months ago
MACD: Sell SignalJan 16, 20269 months ago
RSI: OverboughtJan 9, 20269 months ago
RSI: OverboughtJan 6, 20269 months ago
RSI: OverboughtDec 18, 202510 months ago
SMA: BullishDec 4, 202511 months ago
MACD: Buy SignalDec 2, 202511 months ago
SMA: BullishDec 1, 202511 months ago
SMA: BearishNov 25, 202511 months ago
SMA: BearishNov 3, 202512 months ago
MACD: Sell SignalOct 17, 20251 year ago
RSI: OverboughtOct 7, 20251 year ago
SMA: BullishSep 12, 20251 year ago
MACD: Buy SignalAug 4, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
MACD: Buy SignalJul 30, 20251 year ago
SMA: BearishJul 10, 20251 year ago
SMA: BullishJul 3, 20251 year ago
SMA: BearishJul 1, 20251 year ago
MACD: Sell SignalJun 24, 20251 year ago
MACD: Buy SignalJun 16, 20251 year ago
RSI: OverboughtJun 16, 20251 year ago
MACD: Sell SignalJun 9, 20251 year ago
RSI: OverboughtMay 29, 20251 year ago
RSI: OverboughtMay 23, 20251 year ago
RSI: OverboughtMay 20, 20251 year ago
RSI: OverboughtMay 15, 20251 year ago
RSI: OverboughtMay 5, 20251 year ago
MACD: Buy SignalApr 30, 20251 year ago
RSI: OverboughtApr 30, 20251 year ago
MACD: Sell SignalApr 1, 20251 year ago
RSI: OverboughtMar 25, 20251 year ago
SMA: BullishMar 13, 20251 year ago
MACD: Buy SignalMar 13, 20251 year ago
RSI: OverboughtMar 13, 20251 year ago
MACD: Sell SignalMar 11, 20251 year ago
SMA: BearishMar 3, 20251 year ago
SMA: BullishFeb 26, 20251 year ago
SMA: BearishFeb 25, 20251 year ago
SMA: BullishFeb 24, 20251 year ago
MACD: Buy SignalFeb 14, 20251 year ago
MACD: Sell SignalJan 27, 20251 year ago
MACD: Buy SignalDec 24, 20241 year ago
MACD: Sell SignalDec 23, 20241 year ago
MACD: Buy SignalDec 20, 20241 year ago

Key statistics

Market cap
3.34B
Enterprise value
3.39B
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
249.26
EPS (TTM)
-0.02
Beta
1.17
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-2.99M
Total cash
14.19M
Total debt
295.81K
Return on equity
-128.53%
Shares outstanding
495.88M
Short % of float
0.79%
50-day average
6.80
200-day average
17.29

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
RGC Revenue — annual 0
2019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
RGC Net income — annual -11.70M
2019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
RGC EPS — annual -0.024
2019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026

Earnings

RGC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 28, 2026Jun 30, 2026—-0.0129——
Jun 15, 2026Dec 31, 2025—-0.0107——
Nov 18, 2025Jun 30, 2025—-0.0035——
Jun 26, 2025Dec 29, 2024—-0.14244——
Oct 25, 2024Jun 30, 2024—-0.0045——
Jan 26, 2024Dec 30, 2023—0.00——

About Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Hong Kong

News

Your note

Sign in to keep a note on RGC — it syncs with the Stock Master app.

Institution ownership

RGC institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.09%422,0112.84MJun 29, 2026
Alyeska Investment Group, L.p.0.08%416,2612.80MJun 29, 2026
Legal & General Group PLC0.03%128,000861.44KJun 29, 2026
Jane Street Group, LLC0.02%98,348661.88KJun 29, 2026
Quadrature Capital Ltd0.01%41,750280.98KJun 29, 2026
Amundi0.01%47,159317.38KJun 29, 2026

Fund ownership

RGC fund ownership
Holder% heldSharesValueReported
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund0.06%301,8592.03MAug 30, 2026
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF0.02%121,511817.77KSep 29, 2026
John Hancock Variable Insurance Trust-Total Stock Market Index Trust0.00%7,60251.16KJun 29, 2026
Invesco Exch-Trd Fd. TRT II-Invesco S&P Emerging Markets Momentum ETF0.00%4783.22KAug 30, 2026
SPDR INDEX SHARES FUNDS-State Street SPDR S&P China ETF0.00%4,05127.26KSep 29, 2026
Advertisement